Menu Back toSession-0705-Detection-and-Evaluation-of-Immunogenicity-of-Biologics

The 7th DIA China Annual Meeting


Session 0705 Detection and Evaluation of Immunogenicity of Biologics

Session Chair(s)

Haifeng  Song

Haifeng Song

  • Professor
  • Academy of Military Medical Sciences, China

Recommendations from the AAPS LBABFG Biosimilars Action Program Committee on the Development and Validation of ADA assays for Biosimilars

Speaker(s)

Michael  Anderson

Recommendations from the AAPS LBABFG Biosimilars Action Program Committee on the Development and Validation of ADA assays for Biosimilars

Michael Anderson

  • President and Chief Scientific Officer
  • Biologics Development Services, LLC, USA, China
Eric  Liang

Eric Liang

  • Group Manager/CNIBR DMPK-Biologics
  • Novartis, China
Dongbei  Li

Important Consideration in Anti-drug Antibody Assay Development

Dongbei Li

  • Senior Director, Bioanalytical services
  • Wuxi AppTec, China

Contact us

For exhibition, advertising and hosting inquiry, please contact:
Jean XU: jxu@kellencompany.com, or Sofie Peeters: speeters@kellencompany.com
Tel: +86 10 5923 1096

For general inquiry, please contact DIA China office:
dia@diachina.org
Tel: +86 10 5704 2650